Medtronic, having received FDA approval last year, is now introducing its MiniMed 670G hybrid closed loop insulin delivery system to the U.S. market. The first such system to become available, the MiniMed 670G utilizes Medtronic’s SmartGuard HCL algorithm to deduce when and how much insulin to deliver, yet allowing the patients themselves to (Read more...)